Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Na Zhao
Institutions:
Baylor College of Medicine,
Dan L Duncan Comprehensive Cancer Center
Observed institutions:
Baylor College of Medicine,
Dan L Duncan Comprehensive Cancer Center
ORCID:
0000-0002-8161-3380
Observed ORCID:
0000-0002-8161-3380
OpenAlex ID:
A5121885083
Anti-CSF-1R therapy with combined immuno-chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched triple negative breast cancers
2026
·
Diego A. Pedroza
, Xueying Yuan
, et al.
·
Nature Communications
·
12
MERTK Inhibition Cooperates with Immunomodulatory Cyclophosphamide to Induce CXCL9+ Monocyte–Macrophage Programming and Durable Antitumor Immunity in Triple-Negative Breast Cancer
2026
·
Alex J. Smith
, Zachary Schrank
, et al.
·
Cancer Immunology Research
PDF
Abstract 1576: Combination treatment of mertki and immunomodulatory chemotherapy results in cxcl9 positive macrophage reprogramming and anti tumor adaptive memory in triple negative breast cancer
2026
·
Alex J. Smith
, Zachary Schrank
, et al.
·
Cancer Research
Show more works
View as search
Works count:
3
Citation count:
12
H-index:
1
I10-index:
1
Year
Topic
Type